Cite
HARVARD Citation
Polo, R. et al. (2023). Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers. Clinical microbiology and infection. pp. 85-93. [Online].